New data show strong efficacy of CD388 in phase 2b trial
News
NHS ConfedExpo 2025: a platform for change in UK health and care
This year’s event took place on 11 to 12 June at Manchester Central
Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health
The programme was unveiled at this year’s NHS ConfedExpo in Manchester
2025 PharmaTimes Clinical Researcher of the Year
Enter this year’s famous competition
NHS rolls out new initiative to identify pancreatic cancer earlier
The pilot will see GP practices look at patient records to identify those most at risk
eXmoor and Signadori Bio enter cell therapy partnership
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
Teva and Fosun Pharma partner on early-stage oncology drug
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US
EDX medical partners with spire healthcare to advance disease diagnostics
Collaboration aims to improve rapid detection and personalised treatments
Investigational treatment shows promise for aggressive multiple myeloma
Results suggest bispecific antibody combination could improve outcomes
Levicept presents new LEVI-04 data at EULAR
Biotech firm shares phase 2 findings on novel osteoarthritis treatmen
Migraine takes the spotlight at European Parliament
EMHA calls for its inclusion in EU neurological health strategy
Bimekizumab shows lasting efficacy at EULAR 2025
Three-year data highlights inflammation control in psoriatic arthritis
Argenx presents new efgartigimod data at EULAR 2025
Rheumatology studies show promising results for Sjogren’s disease
Tagomics secures £860k grant for colorectal cancer test
Biotech firm to collaborate with NHS on early detection study
